Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
RPG Life Sciences Limited
RPGLIFERPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, and anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology, cardiovascular, pediatrics, neurology, anti-dengue, and dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust. Address: RPG House, Mumbai, India, 400030
Analytics
WallStreetin tavoitehinta
40 359.09 INRP/E-suhde
50.5011Osinkotuotto
0.75 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut RPGLIFE
Osinkoanalytiikka RPGLIFE
Osinkojen kasvu 5 vuoden aikana
400 %Jatkuva kasvu
4 vuottaMaksusuhde 5 vuoden keskiarvo
30 %Osinkohistoria RPGLIFE
Osakkeen arvostus RPGLIFE
Talousasiat RPGLIFE
Tuloksia | 2019 | Dynamiikka |